Paul J. Gresch - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
serotonin receptors

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhang Z, Shen M, Gresch PJ, Ghamari-Langroudi M, Rabchevsky AG, Emeson RB, Stamm S. Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake. Embo Molecular Medicine. PMID 27406820 DOI: 10.15252/emmm.201506030  1
2014 Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 111: E4779-88. PMID 25331903 DOI: 10.1073/pnas.1417294111  1
2014 Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJ, Gresch PJ, Airey DC, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function. Neurochemistry International. 73: 113-21. PMID 24090638 DOI: 10.1016/j.neuint.2013.09.015  1
2011 Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S. Hippocampal interneurons are abnormal in schizophrenia. Schizophrenia Research. 131: 165-73. PMID 21745723 DOI: 10.1016/j.schres.2011.06.007  1
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proceedings of the National Academy of Sciences of the United States of America. 108: 3785-90. PMID 21282638 DOI: 10.1073/pnas.1011920108  1
2011 Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S. Hippocampal interneurons in bipolar disorder. Archives of General Psychiatry. 68: 340-50. PMID 21135314 DOI: 10.1001/archgenpsychiatry.2010.175  1
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 9, (3785-3790) DOI: 10.1073/pnas.1011920108) Proceedings of the National Academy of Sciences of the United States of America. 108: 6689. DOI: 10.1073/pnas.1104147108  1
2010 Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. Plos Biology. 8: e1000393. PMID 20543991 DOI: 10.1371/journal.pbio.1000393  1
2010 Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology. 209: 163-74. PMID 20165943 DOI: 10.1007/s00213-010-1784-0  1
2007 Hackler EA, Turner GH, Gresch PJ, Sengupta S, Deutch AY, Avison MJ, Gore JC, Sanders-Bush E. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. The Journal of Pharmacology and Experimental Therapeutics. 320: 1023-9. PMID 17138863 DOI: 10.1124/jpet.106.113357  1
2007 Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. The Journal of Pharmacology and Experimental Therapeutics. 320: 662-9. PMID 17077317 DOI: 10.1124/jpet.106.112946  1
2006 Tomlinson ID, Gies AP, Gresch PJ, Dillard J, Orndorff RL, Sanders-Bush E, Hercules DM, Rosenthal SJ. Universal polyethylene glycol linkers for attaching receptor ligands to quantum dots. Bioorganic & Medicinal Chemistry Letters. 16: 6262-6. PMID 17000112 DOI: 10.1016/j.bmcl.2006.09.031  1
2005 Bentzen EL, Tomlinson ID, Mason J, Gresch P, Warnement MR, Wright D, Sanders-Bush E, Blakely R, Rosenthal SJ. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjugate Chemistry. 16: 1488-94. PMID 16287246 DOI: 10.1021/bc0502006  1
2005 Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1693-702. PMID 15756304 DOI: 10.1038/sj.npp.1300711  1
2002 Gresch PJ, Strickland LV, Sanders-Bush E. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience. 114: 707-13. PMID 12220572 DOI: 10.1016/S0306-4522(02)00349-4  1
2002 Smith RL, Gresch PJ, Barrett RJ, Sanders-Bush E. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. Pharmacology, Biochemistry, and Behavior. 72: 77-85. PMID 11900772 DOI: 10.1016/S0091-3057(01)00723-7  1
2001 Campbell BM, Gresch PJ, Walker PD. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum. Neuroscience. 105: 671-80. PMID 11516832 DOI: 10.1016/S0306-4522(01)00218-4  1
1999 Gresch PJ, Walker PD. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience. 93: 831-41. PMID 10473249 DOI: 10.1016/S0306-4522(99)00238-9  1
1999 Gresch PJ, Walker PD. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat. Brain Research. Molecular Brain Research. 70: 125-34. PMID 10381550 DOI: 10.1016/S0169-328X(99)00138-2  1
1999 Gresch PJ, Walker PD. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor. Brain Research. Molecular Brain Research. 67: 190-3. PMID 10101247 DOI: 10.1016/S0169-328X(99)00059-5  1
1995 Ross RJ, Gresch PJ, Ball WA, Sanford LD, Morrison AR. REM sleep inhibition by desipramine: evidence for an alpha-1 adrenergic mechanism. Brain Research. 701: 129-34. PMID 8925274 DOI: 10.1016/0006-8993(95)00984-X  1
1995 Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. Journal of Neurochemistry. 65: 111-6. PMID 7790854  1
1994 Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. Journal of Neurochemistry. 63: 575-83. PMID 8035182  1
1990 Ross RJ, Ball WA, Levitt DR, Gresch PJ, Morrison AR. Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity. Neuropharmacology. 29: 965-8. PMID 2255389 DOI: 10.1016/0028-3908(90)90149-L  1
1990 Ross RJ, Ball WA, Gresch PJ, Morrison AR. REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration. Biological Psychiatry. 28: 231-9. PMID 2165825 DOI: 10.1016/0006-3223(90)90578-P  1
Show low-probability matches.